Blog

  • NanoTemper gets Top 100 award as one of Germany’s most innovative SMEs in 2021

    NanoTemper gets Top 100 award as one of Germany’s most innovative SMEs in 2021

    NanoTemper has been given this year’s TOP 100 seal, an award that honors innovative German small and medium-sized companies. The TOP 100 innovation competition is organized by compamedia, and...

    Read
  • NanoTemper’s Monolith wins top global design award: Red Dot Award

    NanoTemper’s Monolith wins top global design award: Red Dot Award

    NanoTemper’s newest Monolith instrument has been awarded the Red Dot Award, an internationally recognized seal of excellence in design. Both bold aesthetics and user-friendly design have always...

    Read
  • NanoTemper launches Andromeda, helping Biopharma and CROs to increase efficiency of expression screening for membrane proteins

    NanoTemper launches Andromeda, helping Biopharma and CROs to increase efficiency of expression screening for membrane proteins

    SOUTH SAN FRANCISCO, Calif. June 24, 2021 — NanoTemper Technologies, well-known for creating biophysical tools that tackle challenging characterizations, enters the protein production market with...

    Read
  • 5 experiments in biologics that can be improved with dynamic light scattering

    5 experiments in biologics that can be improved with dynamic light scattering

    Biologics, which are drugs and treatments derived from natural products, undergo a long development process before they reach the clinic. When you invest a lot of time and money in the process to...

    Read
  • NanoTemper and SIRION Biotech support Adrian Bleninger’s bid for round-the-world sailing race, the Vendée Globe

    NanoTemper and SIRION Biotech support Adrian Bleninger’s bid for round-the-world sailing race, the Vendée Globe

    NanoTemper Technologies and SIRION Biotech, two of Munich’s rapidly growing biotech companies, are lending their support to Adrian Bleninger, a 30-year-old Bavarian sailor, in his bid to qualify...

    Read
  • ×

    Sign up to receive
    the latest NanoTemper news, product updates, event announcements and more

    First Name
    Last Name
    Company Name
    Country
    State
    Province
    State
    Region
    State
    Canton
    Agree to Subscribe & Privacy Policy*
    *I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

    By completing this form, you provide us consent to contact you with educational content, news and information about our products, services and events. You may unsubscribe at any time.
    Thank you!
    Error - something went wrong!
  • NanoTemper named one of Germany’s most innovative companies in 2021 by Capital

    NanoTemper named one of Germany’s most innovative companies in 2021 by Capital

    For the second year in a row, NanoTemper was named one of the most innovative companies in Germany by Capital magazine. A five out of five star distinction placed NanoTemper in the ranking’s top...

    Read
  • Protein degraders show promising results in drug development pipelines. See what progress candidates have made.

    Protein degraders show promising results in drug development pipelines. See what progress candidates have made.

    There has been considerable and promising development in the field of targeted protein degradation (TPD) since the seminal discovery of PROTACs in 2001.1 The appeal of degraders like PROTACs lies...

    Read
  • NanoTemper’s Monolith wins top global design award: iF DESIGN AWARD 2021

    NanoTemper’s Monolith wins top global design award: iF DESIGN AWARD 2021

    NanoTemper’s newest Monolith instrument has been awarded the globally renowned iF DESIGN AWARD 2021. User-friendly design has always been a core focus in NanoTemper’s product development....

    Read
  • Is your screening campaign stuck? 3 signs that it’s time to look for an alternative biophysical technology

    Is your screening campaign stuck? 3 signs that it’s time to look for an alternative biophysical technology

    Most labs dedicated to drug discovery — in big pharma, biopharma, or CROs — make it a priority to have an adequate lineup of instruments for their screening campaigns. They decide on what...

    Read
  • Have a question?

    Contact Specialist
  • Are you building an effective protein degrader? 4 questions to ask yourself to find out

    Are you building an effective protein degrader? 4 questions to ask yourself to find out

    Protein degraders are getting a lot of attention for being a new and promising modality to treat diseases such as cancer or Alzheimer’s disease. Rather than inhibiting the function of a protein,...

    Read
  • NanoTemper Technologies teams up with PharmAI to help researchers spot game-changing drug candidates from millions of possibilities

    NanoTemper Technologies teams up with PharmAI to help researchers spot game-changing drug candidates from millions of possibilities

    NanoTemper Technologies and PharmAI combine competencies to develop biophysical tools that remove costly and time-consuming guesswork from large datasets. PRESS RELEASE MUNICH, Germany, 24 March...

    Read
  • Follow these 7 tips when pipetting small volumes to get consistent assay results

    Follow these 7 tips when pipetting small volumes to get consistent assay results

    If you’ve ever had to pipette really small volumes, such as what is required in 384-well plates, you’re definitely familiar with the frustrations that come along with it. The concentration alone...

    Read
  • 4 crowdsourced projects that are unraveling the protein folding mystery

    4 crowdsourced projects that are unraveling the protein folding mystery

    As the folding of a protein is intimately linked to its function, more insight into the principles behind protein folding and the correct foldedness of proteins leads to better understanding of...

    Read
  • 6  protein degradation conferences in 2021 you can’t afford to miss

    6 protein degradation conferences in 2021 you can’t afford to miss

    Conferences in 2021 will gather scientists and experts eager to discuss new discoveries in the emerging field of targeted protein degradation (TPD). Many transcription factors, scaffold proteins,...

    Read
  • What is Dynamic Light Scattering (and 4 reasons it’s useful for protein research)

    What is Dynamic Light Scattering (and 4 reasons it’s useful for protein research)

    Any researcher looking to better understand their protein’s behavior can benefit from the information provided by Dynamic Light Scattering (DLS). Here’s an overview of DLS and how it’s useful for...

    Read
  • How to plan for the next steps after your grant submission

    How to plan for the next steps after your grant submission

    Federal grants serve as the bread and butter for funding most, if not all, academic research labs. To write grant proposals and finally submit them is no trivial task. These generally take months...

    Read
  • Can bioanalytical tools solve your neurodegenerative disease research challenges? 4 questions to ask yourself

    Can bioanalytical tools solve your neurodegenerative disease research challenges? 4 questions to ask yourself

    Despite extensive efforts, neurodegenerative diseases (ND) continue to feel like a pharmaceutical frontier. We have yet to see any effective drugs for conditions such as Alzheimer’s, Parkinson’s,...

    Read
  • 3 case studies on how to characterize challenging drug discovery targets — membrane proteins, peptide libraries, and PROTACs

    3 case studies on how to characterize challenging drug discovery targets — membrane proteins, peptide libraries, and PROTACs

    A caveat to a successful pharmaceutical industry in which many effective drugs have already been discovered is the notion that the high hanging fruits left unpicked come in the form of challenging...

    Read
  • How Amgen looks at stability characterization to boost the success of biologics candidates

    How Amgen looks at stability characterization to boost the success of biologics candidates

    Biologic drugs have been incredibly successful in terms of both medical achievement and profitability. Many of these are recombinant proteins and antibodies that treat a myriad of conditions...

    Read
  • The NanoTemper Story – Chapter 6: The Prometheus Panta

    The NanoTemper Story – Chapter 6: The Prometheus Panta

    Take a moment to consider what it would have been like to be a researcher in your field a hundred, fifty, or even twenty years ago. The technology that enables us to make scientific progress is...

    Read
  • loading
    Loading more...